UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HLA‐Cw6 and psoriasis

British journal of dermatology (1951), 2018-04, Vol.178 (4), p.854-862

2018

Volltextzugriff (PDF)

Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial

British journal of dermatology (1951), 2018-01, Vol.178 (1), p.114-123

2018

Volltextzugriff (PDF)

Secukinumab 2‐weekly vs. 4‐weekly dosing in plaque‐type psoriasis

British journal of dermatology (1951), 2021-05, Vol.184 (5), p.791-792

Tsai, T.‐F.

2021

Volltextzugriff (PDF)

Tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: long‐term safety and efficacy in an open‐label extension study

British journal of dermatology (1951), 2018-10, Vol.179 (4), p.853-862

2018

Volltextzugriff (PDF)

Secukinumab in patients with psoriasis who have responded inadequately to tumour necrosis factor inhibitor treatment

British journal of dermatology (1951), 2020-07, Vol.183 (1), p.7-8

Tsai, T.‐F.

2020

Volltextzugriff (PDF)

Clinical experience of secukinumab in the treatment of erythrodermic psoriasis: a case series

British journal of dermatology (1951), 2018-06, Vol.178 (6), p.1439-1440

2018

Volltextzugriff (PDF)

Clinical experience of ixekizumab in the treatment of patients with history of chronic erythrodermic psoriasis who failed secukinumab: a case series

British journal of dermatology (1951), 2019-11, Vol.181 (5), p.1106-1107

2019

Volltextzugriff (PDF)

The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C

British journal of dermatology (1951), 2013-12, Vol.169 (6), p.1295-1303

2013

Volltextzugriff (PDF)

Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12/23 blocker, in Chinese patients with psoriasis: a retrospective analysis

British journal of dermatology (1951), 2014-11, Vol.171 (5), p.1181-1188

2014

Volltextzugriff (PDF)

The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection

British journal of dermatology (1951), 2012-11, Vol.167 (5), p.1145-1152

2012

Volltextzugriff (PDF)

The role of β‐blockers in dermatological treatment: a review

Journal of the European Academy of Dermatology and Venereology, 2018-03, Vol.32 (3), p.363-371

2018

Volltextzugriff (PDF)

Juvenile‐onset pustular psoriasis: case series and literature review

British journal of dermatology (1951), 2020-03, Vol.182 (3), p.816-817

2020

Volltextzugriff (PDF)

Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study

British journal of dermatology (1951), 2015-07, Vol.173 (1), p.146-154

2015

Volltextzugriff (PDF)

The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis

BMC biology, 2020-01, Vol.18 (1), p.10-10, Article 10

2020

Volltextzugriff (PDF)

Functional cooperativity between the trigger factor chaperone and the ClpXP proteolytic complex

Nature communications, 2021-01, Vol.12 (1), p.281-18, Article 281

2021

Volltextzugriff (PDF)

Structural basis of impaired disaggregase function in the oxidation-sensitive SKD3 mutant causing 3-methylglutaconic aciduria

Nature communications, 2023-04, Vol.14 (1), p.2028-2028, Article 2028

2023

Volltextzugriff (PDF)

A case of latent tuberculosis reactivation in a patient treated with ustekinumab without concomitant isoniazid chemoprophylaxis in the PEARL trial

British journal of dermatology (1951), 2013-02, Vol.168 (2), p.444-446

2013

Volltextzugriff (PDF)

Safety in moderate‐to‐severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti‐tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trials

Journal of the European Academy of Dermatology and Venereology, 2020-08, Vol.34 (8), p.1744-1749

2020

Volltextzugriff (PDF)

Physio-Cognitive Decline Syndrome as the Phenotype and Treatment Target of Unhealthy Aging

The Journal of nutrition, health & aging, 2021, Vol.25 (10), p.1179-1189

2021

Volltextzugriff (PDF)

Hepatitis B virus reactivation after ustekinumab treatment: reply from authors

British journal of dermatology (1951), 2014-02, Vol.170 (2), p.478-479

Tsai, T.-F.

2014

Volltextzugriff (PDF)

Overlapping and Specific Functions of the Hsp104 N Domain Define Its Role in Protein Disaggregation

Scientific reports, 2017-09, Vol.7 (1), p.11184-11, Article 11184

2017

Volltextzugriff (PDF)

Haemorrhagic bullous pyoderma gangrenosum following COVID‐19 vaccination

Journal of the European Academy of Dermatology and Venereology, 2022-08, Vol.36 (8), p.e611-e613

2022

Volltextzugriff (PDF)

Psoriasis sparing the lower limb with postpoliomyelitis residual paralysis

British journal of dermatology (1951), 2014-08, Vol.171 (2), p.429-431

2014

Volltextzugriff (PDF)

HLA‐Cw6 and psoriasis

British journal of dermatology (1951), 2018-04, Vol.178 (4), p.e305-e305

2018

Volltextzugriff (PDF)

HLA‐Cw6和银屑病

British journal of dermatology (1951), 2018-04, Vol.178 (4), p.e320-e320

2018

Volltextzugriff (PDF)

1 – 25 von 13.226

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10.032)
Mit Volltextzugriff
(11.066)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(9.429)
Life Sciences & Biomedicine
(5.193)
Humans
(4.036)
Technology
(3.267)
Male
(2.689)
Female
(2.578)
Biological And Medical Sciences
(2.394)
Physical Sciences
(2.033)
Medical Sciences
(1.838)
Adult
(1.655)
Middle Aged
(1.614)
Computer Science
(1.523)
Animals
(1.475)
Computer Science, Information Systems
(1.208)
Aged
(1.204)
Computer Science, Artificial Intelligence
(1.198)
Engineering
(1.195)
Physics
(1.140)
Robotics
(1.103)
Exact Sciences And Technology
(1.003)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(5.405)
Ingenta
(4.955)
EZB Electronic Journals Library
(4.138)
Journals@Ovid
(3.254)
Elsevier ScienceDirect Journals
(2.612)
Publisher website
(2.207)
IEEE/IET Electronic Library (IEL)
(2.176)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.795)
Wiley-Blackwell Journals
(1.574)
IngentaConnect Journals
(1.418)
Wiley Online Library
(1.225)
Springer journals
(734)
Oxford journals
(561)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(470)
Taylor & Francis Journals
(437)
Taylor & Francis
(381)
Taylor & Francis Online
(371)
Nature Journals
(364)
Oxford Journals 2020 Medicine
(345)
American Institute of Physics (AIP) Journals
(325)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

HLA‐Cw6 and psoriasis

Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial

Secukinumab 2‐weekly vs. 4‐weekly dosing in plaque‐type psoriasis

Tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: long‐term safety and efficacy in an open‐label extension study

Secukinumab in patients with psoriasis who have responded inadequately to tumour necrosis factor inhibitor treatment

Clinical experience of secukinumab in the treatment of erythrodermic psoriasis: a case series

Clinical experience of ixekizumab in the treatment of patients with history of chronic erythrodermic psoriasis who failed secukinumab: a case series

The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C

Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12/23 blocker, in Chinese patients with psoriasis: a retrospective analysis

The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection

The role of β‐blockers in dermatological treatment: a review

Juvenile‐onset pustular psoriasis: case series and literature review

Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study

The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis

Functional cooperativity between the trigger factor chaperone and the ClpXP proteolytic complex

Structural basis of impaired disaggregase function in the oxidation-sensitive SKD3 mutant causing 3-methylglutaconic aciduria

A case of latent tuberculosis reactivation in a patient treated with ustekinumab without concomitant isoniazid chemoprophylaxis in the PEARL trial

Safety in moderate‐to‐severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti‐tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trials

Physio-Cognitive Decline Syndrome as the Phenotype and Treatment Target of Unhealthy Aging

Hepatitis B virus reactivation after ustekinumab treatment: reply from authors

Overlapping and Specific Functions of the Hsp104 N Domain Define Its Role in Protein Disaggregation

Haemorrhagic bullous pyoderma gangrenosum following COVID‐19 vaccination

Psoriasis sparing the lower limb with postpoliomyelitis residual paralysis

HLA‐Cw6 and psoriasis

HLA‐Cw6和银屑病

Suchergebnisse filtern